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ABSTRACT
NUMB, and its close homologue NUMBL, behave as tumor suppressor genes 
by regulating the Notch pathway. The downregulation of these genes in tumors 
is common, allowing aberrant Notch pathway activation and tumor progression. 
However, some known differences between NUMB and NUMBL have raised unanswered 
questions regarding the redundancy and/or combined regulation of the Notch pathway 
by these genes during the tumorigenic process. We have found that NUMB and 
NUMBL exhibit mutual exclusivity in human tumors, suggesting that the associated 
tumor suppressor role is regulated by only one of the two proteins in a specific cell, 
avoiding duplicate signaling and simplifying the regulatory network. We have also 
found differences in gene expression due to NUMB or NUMBL downregulation. These 
differences in gene regulation extend to pathways, such as WNT or Hedgehog. In 
addition to these differences, the downregulation of either gene triggers a cancer 
stem cell-like related phenotype. These results show the importance of both genes 
as an intersection with different effects over cancer stem cell signaling pathways. 
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INTRODUCTION
NUMB and NUMBL, or NUMB-Like, belongs to 
a closely conserved family of proteins with important 
roles in a large variety of cellular processes ranging from 
cell adhesion to ubiquitination [1–7]. NUMB, the first 
gene in the family identified in Drosophila [8], has been 
suggested to play a role in asymmetric division, allowing 
cell differentiation [7]. Most research conducted to date 
has been focused on the role of NUMB, assuming that 
NUMBL performs the same functions, although NUMBL 
does not display an asymmetric distribution in cells 
during mitosis [9]. In addition, its expression is different 
during development, with ubiquitous NUMB expression 
and more restricted expression of NUMBL in the central 
nervous system [6, 9–11]. Knock-out experiments in mice 
have shown that, although NUMBL deletion showed no 
differences during embryogenesis, the deletion of NUMB 
or combined NUMB/NUMBL deletion were embryonic 
lethal [6, 12, 13]. Together, these differences show that, 
although NUMB and NUMBL have a conserved structure 
and domains [14], the functional differences between the 
proteins must also be considered.
NUMB and NUMBL have been characterized 
as tumor suppressor genes [15–17], leading to Notch 
signaling pathway inhibition [4, 17] or p53 stabilization 
[18, 19]. NUMB inhibits the Notch pathway through its 
interaction with ITCH and NICD (Notch IntraCellular 
Domain), labeling NICD for ubiquitination and 
degradation [4, 20–22]. Although this is one of the most 
known roles of NUMB, this protein has also been linked 
to the WNT pathway, promoting β-catenin degradation 
through polyubiquitination [23]. The role of NUMB as 
a tumor suppressor gene has been widely characterized, 
revealing that lower NUMB levels are associated with 
a worse prognosis in malignant pleural mesothelioma 
[24]. In addition, different tumors, such as breast cancer, 
salivary gland carcinoma, non-small-cell lung carcinoma 
or medulloblastoma, also exhibit a downregulation 
of NUMB expression [25–28]. Conversely, NUMB 
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overexpression reduces cell proliferation and increases 
cell sensitivity to cisplatin [24, 25, 29]. 
Previous results obtained by NUMBL knockdown 
by shRNA, with no changes in NUMB levels, showed an 
increment in tumorigenic properties and increased resistance 
to chemotherapy, with a worse prognosis in breast, lung and 
colorectal tumors [17]. Importantly, the downregulation of 
NUMBL also triggers Notch pathway activation, further 
increasing the epithelia-mesenchymal transition (EMT), 
cancer stem cell (CSC) transcriptional markers and CSC-
like phenotypes. NUMBL has also been described as a 
tumor suppressor gene, mainly based on its ability to inhibit 
the Notch pathway [17, 30, 31]. However, NUMBL can also 
activate Hedgehog signaling, which represents a functional 
difference compared with NUMB [32]. According to these 
results, NUMBL can activate Hedgehog signaling and 
thus increase the stem cell population. This phenomenon 
suggests that, under certain circumstances, NUMBL could 
act as an oncogene. This process has also recently been 
described for NUMB, showing that an altered isoform 
expression is common in cancer cells [23, 33–35]. 
A small percentage of human tumors exhibit 
lower NUMBL expression than normal tissue, being this 
reduced expression associated with a poor prognosis and 
worse patient survival [30, 31]. Inhibition of only one 
NUMB family protein is sufficient to modify cancer cell 
properties, since a partial decrease in NUMB or NUMBL 
is sufficient to increase Notch pathway activation and 
cancer stem-like properties. This phenomenon suggests 
that NUMB and NUMBL act as essential regulators of 
cancer cell properties, individually acting in a dose-
dependent manner and regulating the same pathway with 
a certain degree of redundancy. Like NUMB, NUMBL 
seems to regulate Notch pathway activity [36, 37]. It is 
interesting to note that the downregulation of only one 
of these proteins, either NUMB or NUMBL, is sufficient 
to allow Notch pathway activation, increasing the pool 
of CSC-like cells [38–41]. However, whether there is a 
dose effect of combined NUMB/NUMBL or whether the 
downregulation of both proteins may coexist in some very 
aggressive tumors remains unknown. Such an additive 
effect still must be demonstrated, as well as whether the 
accumulative effects are linear or reach a certain threshold 
with no further increases in tumorigenicity. Finally, the 
effects of the distinct tumor suppressor activities on 
different pathways in cells must be elucidated. 
Here, we showed the mutual exclusivity of NUMB 
and NUMBL in tumors and the opposite gene regulation 
affecting at least three different signaling pathways: 
Notch, WNT and Hedgehog. Although both genes equally 
regulate Notch, the WNT and Hedgehog pathways are 
oppositely regulated by NUMB and NUMBL, according 
to our gene transcription analysis. However, the final 
phenotypic endpoint induced by NUMB or NUMBL 
downregulation was similar, suggesting some hierarchy in 
the signaling pathways.
RESULTS
NUMB and NUMBL show a negative correlation 
in tumors
As mentioned above, NUMB and NUMBL are 
commonly described as proteins with a very similar 
function, characterized as tumor suppressors. To identify 
any differential effects in tumors, we analyzed a total of 
95 datasets in ten different tumors (Acute Lymphoblastic 
Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic 
Leukemia, ovarian colon/rectal, lung, renal breast, 
neuroblastoma or esophageal tumors) using R2 software. 
We observed a clearly marked trend between NUMB and 
NUMBL since were negatively correlated in 72 of the 95 
considered datasets (Figure 1A). Indeed, the correlation 
of NUMB and NUMBL expression provided a significant 
Pearson value (R = –0.355, p = 4.4 × 10–4) (Figure 1B), as 
clearly shown in the heat maps of tumors from colon, lung, 
breast, endometrium or kidney, in which individual samples 
can be compared (Figure 1C). These results, which were 
obtained directly from human tumor samples, showed that 
when one of these genes was highly expressed in tumors, 
the other was expressed at a lower rate. In fact, we also 
explored datasets derived from normal samples. We found 
that the negative correlation of NUMB/NUMBL was also 
present in non-tumoral samples, showing that both genes are 
to some extent mutually exclusive in cells (Supplementary 
Figure 1). This result suggests a stringent gene regulation 
to avoid undesirable effects. These differences might be 
due to differences in gene methylation, allowing higher 
expression of one of the genes in cells. To explore this 
phenomenon, we looked for changes in NUMB or NUMBL 
methylation using TCGA Wanderer resource [42]. By 
doing this, we found that NUMB is highly methylated 
in tumors regarding control (Figure 2A). However, the 
opposite happens with NUMBL, being highly methylated 
in normal samples but not in tumoral samples (Figure 2B). 
Differences in NUMB or NUMBL methylation between 
normal and tumoral samples appear to be general, as can 
be deduced from the fact that a common patron is obtained 
using four different CG probes (Figure 2C). At that way, 
for NUMB, methylation is higher in tumoral samples 
regarding control samples, while for NUMBL occurs the 
opposite. In addition, if we focus in the probe cg01582648, 
the percentage of tumoral samples with a methylation beta 
value higher than 0.8 is significantly higher regarding 
normal samples  in breast invasive carcinoma (80.9% vs. 
33.3%), colon adenocarcinoma (69.8% vs. 5.2%) and lung 
adenocarcinoma (88.8% vs. 71.6%) (Figure 2D). Again, 
the opposite happen for NUMBL probe cg20525355, 
being tumoral samples lower methylated regarding normal 
samples in colon adenocarcinoma (61% vs. 94.7%) and 
lung adenocarcinoma (75.8% vs. 100%) (Figure 2E). These 
results point to the possibility that NUMB or NUMBL 
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might be preferentially expressed in a specific cell or tissue. 
Furthermore, suggest certain redundancy in the roles.
NUMB and NUMBL have few common genes 
with the same correlations
To identify the genes that correlated to NUMB 
and/or NUMBL in the same tumors, we performed the 
following analysis. We first selected public datasets from 
transcriptomic analyses of lung, cervical, breast and 
colorectal tumors (Supplementary Table 1). Next, we 
determined the genes that correlated to NUMB or NUMBL 
in all considered tumor types and then compared the 
individual tumor types to obtain a map of common genes 
correlating to NUMB or NUMBL expression in various 
tumors. We found 675 genes that were positively correlated 
and 691 genes that were negatively correlated to NUMBL 
in at least three of the considered tumor types. Regarding 
NUMB, we found 350 genes that were positively 
correlated and 108 genes that were negatively correlated, 
taking into account at least three of the tumors (Figure 3, 
Supplementary Table 2). Due to the previously assumed 
overlapping functions of NUMB and NUMBL in cells, 
it would be expected to find genes that were positively 
or negatively correlated to NUMB and NUMBL. In our 
bioinformatics analysis of tumors considering all tumor 
types, no common genes from public transcriptome tumor 
datasets were positively correlated both to NUMB and 
NUMBL. However, we obtained a short list of 5 genes that 
were negatively correlated both to NUMB and NUMBL (as 
expected from its behavior as tumor suppressors), a second 
list of 21 genes that were positively correlated to NUMB 
and negatively correlated to NUMBL, and two genes 
negatively correlated to NUMB and positively correlated 
Figure 1: NUMB and NUMBL are negatively correlated in human tumors. (A) NUMB/NUMBL correlations in leukemia, 
ovarian, colon, lung, kidney, breast, neuroblastoma and esophagus tumors, showing a higher percentage of negative correlations. (B) 
Correlation of NUMB and NUMBL expression in human tumors, showing a significant Pearson correlation coefficient (R = –0.355, 
p = 4.4 × 10–4). (C) Heat map of NUMB and NUMBL expression in human tumors. 
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to NUMBL (Figure 4). However, when we compared the 
genes that were correlated to NUMB or NUMBL in each 
individual tumor type, we found common positively or 
negatively correlated genes, suggesting that NUMB and 
NUMBL participate in different gene regulatory processes, 
depending on the tissue (Supplementary Table 3).
Gene ontology analysis of NUMB and/or 
NUMBL correlations
Next, we performed Gene Ontology (GO)-term and 
Reactome enrichment analysis, considering separately 
the genes correlated to NUMB or NUMBL, due to the low 
Figure 2: Changes in NUMB/NUMBL methylation in tumoral samples. (A) Percentage of NUMB methylation for cg0158648 
probe in six different tumors. Breast: Breast invasive carcinoma; COAD: Colon adenocarcinoma; READ: Rectum adenocarcinoma; 
LUAD: Lung adenocarcinoma; LUSC: Lung squamous cell carcinoma; Cervix: cervical squamous cell carcinoma and endocervical 
adenocarcinoma. (B) Percentage of NUMBL methylation for cg20525355 probe in six different tumors. (C) NUMB and NUMBL are 
differentially methylated in normal or tumoral samples. Red color: tumoral samples with a lower methylation value regarding normal 
samples. Blue color: tumoral samples with a higher methylation value regarding normal samples. (D) Relation between expression and 
methylation value for NUMB, using cg0158648 probe, in breast invasive carcinoma, colon adenocarcinoma and lung adenocarcinoma. 
(E) Relation between expression and methylation value for NUMBL, using cg20525355 probe, in breast invasive carcinoma, colon 
adenocarcinoma and lung adenocarcinoma. The Student’s T test was used to determine significant differences (*= p < 0.05; **= p < 0.01; 
***= p < 0.001).
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number of common genes (Supplementary Table 4–7). 
Interestingly, we obtained common GO and Reactome 
terms for genes negatively correlated with NUMB or 
NUMBL (Supplementary Table 8). In particular, we 
found negative correlations with protein synthesis (from 
ribosome to mRNA maturation), general metabolism or 
protein transport. In addition, we found Reactome terms 
related to cell cycle, suggesting a possible deregulation 
due to changes in NUMB or NUMBL expression 
(Supplementary Table 8). At that way, one of the common 
genes negatively correlated both to NUMB and NUMBL 
was CDK4, a known gene connected to cell division. 
In addition, we also found components (MCM3 for 
NUMBL and MCM2 for NUMB) of the minichromosome 
maintenance protein (MCM) complex, necessary for cell 
cycle transition to S-phase [43]. These results can be 
related to the functions of NUMB and NUMBL as negative 
regulators of cell division, supporting their roles as tumor 
suppressor genes. 
From the list of genes that positively correlated with 
either NUMB or NUMBL, similar GO-terms could not be 
obtained. However, it is interesting to note that, regarding 
NUMB, some GO-terms were related to vesicle transport, 
a previously known NUMB function [44, 45] (Table 1). 
However, NUMBL appeared to be positively correlated 
to genes related to gene regulation and RNA metabolism 
(Table 2), suggesting an unexplored role for this gene.
Genes that were negatively correlated to NUMBL 
resulted in a very extensive list of GO and Reactome terms, 
some of which were related to three different signaling 
pathways: NF-κB, WNT and Hedgehog, suggesting that, 
as previously reported [32], NUMBL could modulate 
the Hedgehog pathway (Table 3). We also found that 
NUMBL was negatively correlated to NF-kB signaling, 
Figure 3: Venn diagram of genes positively and negatively correlated to NUMB or NUMBL in breast, lung, colon and 
cervix tumors (p-value < 0.05). 
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mitochondrial tricarboxylic acid cycle (TCA) and p53 
stabilization, as also previously described [30, 46, 47].
NUMB and NUMBL show opposite correlations 
in some signaling pathways
NUMB and NUMBL have been previously 
described as inhibitors of the Notch pathway due to their 
interactions with NICD, allowing it to be labeled for 
ubiquitination and degradation. However, we did not find 
any GO or Reactome term clearly related to the Notch 
pathway, so we decided to search specifically for genes 
related to this pathway. We also searched for genes in the 
WNT and Hedgehog pathways since both pathways were 
negatively correlated with NUMBL (Table 3). A significant 
percentage of genes related to the Notch pathway showed 
the same behavior according to the presence of NUMB 
or NUMBL (Figure 5). Genes such as CFLAR, EP300, 
GBP2, HEYL, KLF7, NOTCH1 or POFUT showed a 
similar correlation with NUMB or NUMBL in the three 
tumor types considered (Figure 5). However, many of 
the genes correlating with NUMBL showed an opposite 
behavior with NUMB in the other two analyzed pathways, 
WNT and Hedgehog (Figure 5), independently of the type 
of tumor. These results indicated that NUMB and NUMBL 
could differentially modulate different signaling pathways 
in a very different fashion. These results also indicate 
that besides the previously observed exclusivity, the full 
redundancy does not exist between these two genes. Only 
in the Notch pathway, equal regulation is maintained.
To experimentally assess this opposite gene 
regulatory role, we decided to analyze gene expression 
using T47D and HeLa cells transfected with specific 
shRNAs against NUMB or NUMBL (Figure 6A). Focusing 
on genes in the Notch pathway, we observed an equivalent 
activation of this pathway due to the downregulation of 
NUMB or NUMBL (Figure 6B), correlating with previous 
reports [17, 48]. Due to the relevance of the different gene 
associations with NUMB and NUMBL, we extended our 
analysis to the other two signaling pathways, WNT and 
Hedgehog. As expected from the bioinformatics analysis, 
we found opposite results due to the downregulation of 
NUMB or NUMBL in the mRNA levels of the target genes 
TCF4, EN1, SOX9 and BTRC, which are considered read-
outs of the WNT pathway (Figure 6C); or PTCH1, GLI1, 
GLI2 and CDH1, considered read-outs of the Hedgehog 
pathway (Figure 6D).
Our bioinformatics results also led us to analyze other 
genes with opposite correlations in tumors, such as NFκB1, 
ERBB2 and TEAD1. Measurement of the transcriptional 
responses of these genes to the reduced expression of 
NUMB or NUMBL revealed an opposite regulation of 
these genes in response to NUMB or NUMBL (Figure 6E), 
as expected based on our bioinformatics analysis. It is 
Figure 4: Venn diagram of genes positively or negatively correlated to NUMB or NUMBL, showing coincident genes.
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interesting to note that these three genes are part of other 
signaling pathways (NFκB, ERBB/HER and Hippo) [49–
51], likely suggesting complex interaction of NUMB/L 
proteins with the signaling network.
NUMB and NUMBL downregulation equally 
increases stem cell properties
Although NUMB and NUMBL downregulation 
act differently regarding some of the considered genes, 
suggesting that NUMB and NUMBL target some different 
pathways, the global effect caused by their downregulation 
is very similar. To explore this point, we decided to 
measure the expression of some genes associated with the 
acquisition of stem cell-like properties and observed a clear 
increment in SOX2, BMI1 and NANOG genes in response 
to both NUMB and NUMBL downregulation (Figure 7A), 
which have been previously related to stem cell properties 
[52–54]. The increment in the transcription of stem cell-
like genes, together with the previously described increment 
in other stem cell-like genes related to NUMB or NUMBL 
downregulation, such as OCT4 or KLF4, showed that, 
for all analyzed conditions, the cells acquire a more de-
differentiated state, typical of stem-like cells [17, 48].
To rate these stem cell-like properties, we cultured 
cells at a low density, so that individual clones formed 
independent colonies. These clones can be classified as 
holoclones, meroclones and paraclones, according to 
their ability to reconstitute a tumor [55, 56]. Holoclones 
are considered to derive from cells with stem cell-like 
properties. We found that either NUMB or NUMBL 
downregulation caused similar increments in the 
Table 1: GO-terms obtained from genes positively correlated with NUMB
GO-term Fold enrichment p-value
vesicle targeting 8.47 2.76 × 10–4
COPII vesicle coating 8.37 0.0161
vesicle targeting, rough ER to cis-Golgi 8.37 0.0161
vesicle coating 8.12 0.0207
COPII-coated vesicle budding 7.87 0.0264
vesicle targeting, to, from or within Golgi 7.76 0.0298
actomyosin 6.9 0.0372
establishment of vesicle localization 4.76 3.19 × 10–4
vesicle localization 4.53 6.87 × 10–4
Golgi vesicle transport 4.04 2.34 × 10–4
Vesicle organization 3.47 0.0341
vesicle-mediated transport 2.27 5.75 × 10–3
Golgi subcompartment 2.27 0.0332
Golgi apparatus 2.08 5.66 × 10–4
cytoplasmic vesicle 1.85 4.58 × 10–4
intracellular vesicle 1.85 4.82 × 10–4
vesicle 1.53 1.58 × 10–3
Table 2: GO-terms obtained from genes positively correlated with NUMBL
GO-term Fold Enrichment p-value
transcription, DNA-templated 1.89 1.31 × 10–8
nucleic acid-templated transcription 1.89 1.35 × 10–8
RNA biosynthetic process 1.88 1.71 × 10–8
nucleobase-containing compound biosynthetic process 1.72 1.94 × 10–6
DNA binding 1.71 4.75 × 10–5
RNA metabolic process 1.64 3.86 × 10–6
regulation of RNA metabolic process 1.53 1.30 × 10–4
regulation of RNA biosynthetic process 1.51 1.25 × 10–3
regulation of transcription, DNA-templated 1.51 1.25 × 10–3
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percentages of holoclones of HeLa and T47D cells 
(Figure 7B). In addition, tumorspheres, colonies derived 
from stem cell-like cells that grow in suspension, showed 
a significant increment in number in both cell lines, 
demonstrating again that NUMB/NUMBL downregulation 
increased stem cell-like properties (Figure 7C), regardless 
of the differences in pathway activation.
DISCUSSION
NUMB and NUMBL have been considered tumor 
suppressor genes with very similar functions because both 
can regulate the Notch pathway [5, 17, 22, 30, 57–59]. 
Our initial analysis in human tumors showed that both 
genes are negatively correlated in more than 75% percent 
of the considered datasets (72 out 95 different datasets). In 
addition, their expression in non-tumoral samples, which 
is close to 75%, shows that this opposite regulation is 
a common effect in human cells. Their role as negative 
regulators of the Notch pathway likely requires a higher 
transcription of one of the genes than the other, allowing 
only one of the two proteins to effectively perform its 
regulatory role. This notion is supported by development 
studies conducted in mouse and chicken embryos, where 
NUMB is broadly expressed, while NUMBL appears to be 
enriched in the developing central nervous system [9–11].
Our previous results have focused on the 
downregulation of NUMB or NUMBL by shRNA [17, 
48]. We showed that only that the downregulation of only 
NUMB or NUMBL causes an increment in the tumorigenic 
properties of cells, allowing us to focus on their roles as 
tumor suppressor genes. Therefore, cells with lower NUMBL 
levels are more resistant to drugs that are commonly used in 
cancer chemotherapy, such as doxorubicin or vincristine [17]. 
In fact, loss of NUMBL protein has been associated with an 
increase in metastasis and worse survival [60]. 
Our bioinformatics analysis allowed us to obtain 
an unexpected network of gene correlations with 
NUMB or NUMBL. Due to their accepted roles as genes 
with similar functions, we expected to find common 
correlations for both genes in different tumors. However, 
our analysis showed that NUMB and NUMBL exhibited 
Table 3: GO and Reactome pathways terms related to Hedgehog, WNT and NF-κB pathways, obtained from genes 
negatively correlated with NUMBL
GO-term Fold enrichment p-value
NIK/NF-kappaB signaling 5.15 3.62 × 10–3
respiratory electron transport chain 4.55 4.37 × 10–5
Wnt signaling pathway, planar cell polarity pathway 4.68 5.27 × 10–3
Reactome pathways term Entities p-Value Entities FDR
Hedgehog ‘off’ state 1.72 × 10–3 0.0137
GLI3 is processed to GLI3R by the proteasome 3.06 × 10–6 9.18 × 10–5
Degradation of GLI2 by the proteasome 3.06 × 10–6 9.18 × 10–5
Degradation of GLI1 by the proteasome 3.06 × 10–6 9.18 × 10–5
Hedgehog ligand biogenesis 1.74 × 10–5 2.44 × 10–4
Hh mutants that don’t undergo autocatalytic processing are degraded 
by ERAD 1.16 × 10
–5 2.06 × 10–4
Hh mutants abrogate ligand secretion 2 × 10–5 2.65 × 10–4
Beta-catenin independent WNT signaling 2.63 × 10–3 0.021
Degradation of beta-catenin by the destruction complex 1.7 × 10–5 2.44 × 10–4
Degradation of AXIN 5.47 × 10–6 1.26 × 10–4
Autodegradation of Cdh1 by Cdh1:APC/C 3.7 × 10–6 9.62 × 10–5
Dectin-1 mediated noncanonical NF-kB signaling 2.72 × 10–5 3.26 × 10–4
Activation of NF-kappaB in B cells 6.81 × 10–5 6.81 × 10–4
TNFR2 non-canonical NF-kB pathway 2.4 × 10–3 0.0192
NIK––>noncanonical NF-kB signaling 1.16 × 10–5 2.06 × 10–4
Citric acid cycle (TCA cycle) 2.58 × 10–4 2.58 × 10–3
The citric acid (TCA) cycle and respiratory electron transport 5.75 × 10–9 9.03 × 10–7
Stabilization of p53 1.69 × 10–6 7.61 × 10–5
p53-Dependent G1 DNA Damage Response 1.26 × 10–5 2.06 × 10–4
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almost independent correlations when we considered the 
four tumor types. This result could be due to different 
regulatory mechanisms, depending on the tissue in which 
NUMB or NUMBL is expressed. A comparison of each 
tumor type allowed us to identify a small number of 
genes that were equally related to NUMB and NUMBL, 
different genes related to similar functions, and genes 
with differential expression. GO-terms obtained with 
the different lists of genes that were correlated to NUMB 
described functions such as endocytic protein with 
important roles in protein transport [2, 3, 44, 45]. GO-
terms related to NUMBL were related to gene transcription 
and some of its previously described roles [17, 31, 61]. In 
addition, common GO and Reactome terms obtained from 
negative correlations to NUMB or NUMBL proceeded 
from different list of genes, pointing to a different gene 
regulation network. These data may confirm the different 
cellular roles of each protein. 
The Notch pathway is involved in the maintenance 
of tumor stemness and cancer metastasis. This pathway 
is activated in different tumors, such as lung, colon, 
breast and prostate tumors, and in sarcomas, melanomas, 
leukemias and lymphomas [58, 59, 62–65]. In addition, 
Notch activity has been linked to cancer metastasis by 
inducing EMT, tumor angiogenesis processes and anoikis 
resistance of tumor cells [66, 67]. After its interaction 
with a ligand, Notch is proteolytically cleaved, and 
NICD is released into the cytoplasm, allowing its nuclear 
translocation [68, 69]. We have recently showed that 
NUMBL behaves, such as NUMB, its close relative, as 
a tumor suppressor gene regulating the Notch pathway. 
Here, we showed that NUMB and NUMBL presented 
mutual exclusivity in tumors, suggesting that the tumor 
suppressor effect on the Notch pathway is regulated by 
one protein at a time, thus simplifying the regulatory 
network. In addition, NUMB and NUMBL also showed 
opposite correlations in non-tumoral samples, suggesting 
that this opposite relationship is a common effect in cells. 
However, the two proteins, which share approximately 
55% of their amino acid sequence, did not show total 
redundancy, as deduced from the differences in mRNA 
levels observed for genes belonging to the NFκB, ERBB/
HER, Hippo, WNT and Hedgehog pathways. Thus, 
our results obtained by downregulation of NUMBL are 
consistent with previously published studies showing 
that NUMBL negatively influences the NFκB pathway 
and positively affects the Hedgehog pathway [31, 32]. In 
addition, although GLI1 and GLI2 should have similar 
behaviors, considering their transcription is activated by 
Hedgehog signaling and appear to be downregulated when 
the Hedgehog pathway is inactive, GLI1 is also connected 
to Notch signaling through HES1 inhibition [70, 71]. The 
large number of genes that are transcriptionally affected 
in an opposite manner suggests that NUMB and NUMBL 
Figure 5: Upper figure: Notch, Hedgehog and WNT pathway genes with an opposite correlation for NUMB and 
NUMBL. Statistical differences, obtained from gene correlations, are the followings: *= p < 0.05; **= p < 0.01; ***= p < 0.001. Bottom 
figure: Graph representative of the genes equally regulated vs. opposite regulated for each pathway in breast, lung and colon tumors.
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have different effects on the signaling pathways (Figure 8). 
Since the phenotypic effect of NUMB and NUMBL 
downregulation is similar, inducing CSC-like properties, 
this finding suggest a hierarchy of Stem Cell pathways in 
which Notch pathway activation predominates over the 
other affected pathways, inducing an increase in stemness 
due to the lower levels of NUMB or NUMBL.
A possible explanation for the different effects on 
different pathways, correlating genes to either an oncogene 
or a tumor suppressor, may be plausible if we consider 
recent results correlating the alternative splicing of NUMB 
in tumors. p72/p71 NUMB isoforms have been shown 
to be induced by RAS-ERK signaling in breast and lung 
cancer [49]. An analysis of all NUMB and NUMBL protein 
isoforms has shown that only NUMB p72/p66 exhibits the 
entire sequence of the PTB domain, with the absence of an 
11-amino-acid sequence starting after Ala67 in the other two 
isoforms, p71/p65. In addition, only p72/p71 exhibits the 
48-amino-acid sequence that corresponds to exon 9, which 
has been linked to an increase in tumorigenic properties 
[49]. NUMBL also lacks this region, although protein 
homology between NUMB and NUMBL in this region is 
low, sharing less than 30% of the sequence between Ser373 
and Leu574 from NUMBL. Thus, it is plausible that the 
NUMB and NUMBL isoforms are essential in terms of their 
different regulatory effects on the properties of cancer.
Expression data from public datasets, although a 
powerful tool to obtain useful information, may not detect 
Figure 6: (A) Transfection of HeLa or T47D cells with NUMB or NUMBL-shRNA plasmids induces a decrease in protein and mRNA 
expression, as detected by WB and qPCR. (B) NUMB and NUMBL downregulation modifies mRNA levels of Notch pathway-related 
genes. (C) NUMB and NUMBL downregulation modify the expression of genes in the WNT pathway in an opposite manner. (D) Changes 
in Hedgehog related genes due to NUMB or NUMBL downregulation. (E) NUMB or NUMBL downregulation results in opposite changes 
in gene expression of the NFκB, ERBB/HER and Hippo pathways. All experiments were repeated a minimum of three independent times. 
The Student’s T test was used to determine significant differences (*= p < 0.05; **= p < 0.01; ***= p < 0.001).
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alternative splicing. Thus, although both NUMB and 
NUMBL are considered tumor suppressors, an increment 
in the expression of at least NUMB cannot be assumed 
to lead to an increase in a tumor suppressor gene due to 
the observed alternative splicing. In accordance with this 
hypothesis, NUMB levels are higher in astrocytomas and 
cervical squamous carcinoma cells, and the positive effect 
of NUMBL over SHH signaling can also promote tumor 
progression [23, 33, 34, 49]. Therefore, explorations of the 
effects of NUMB and NUMBL should not only consider 
the expression of both genes individually but also the 
relative levels of their different isoforms.
Alternatively, these differences might be derived 
from differences in the affinity of NUMB/NUMBL for 
its targets. In agreement with the previous hypothesis, 
NICD1 and NICD2, the processed intracellular domains 
of Notch1 and Notch2, showed similar effects over HES1 
induction, while transcription of sequences upon the 
Figure 7: (A) Changes in the expression of genes related to stem cell properties due to NUMB or NUMBL downregulation. (B) Holoclone 
percentages are increased as a consequence of NUMB or NUMBL downregulation. (C) The number and area of tumorspheres are modified 
due to NUMB or NUMBL downregulation. All experiments were repeated a minimum of three independent times. The Student’s T test was 
used to determine significant differences (*= p < 0.05; **= p < 0.01; ***= p < 0.001).
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four tandem CSL binding sites, typical of the promoters 
of other genes, were different [72]. In addition, the four 
NICD domains have been shown to be targets for different 
post-translational modifications, from ubiquitination 
to acetylation. The latter is particularly important 
because NICD1 acetylation has been shown to provide 
protection against degradation [34, 73]. Therefore, it is 
possible that NUMB and NUMBL preferentially target 
a different NICD member (not acetylated), explaining 
the observed differences in gene expression. In addition, 
Notch receptors have been shown to be differentially 
affected by Numb in mice [74]. Considering the presence 
of four different NUMB isoforms, NUMBL, the four 
Notch receptors and Notch’s multiple post-translational 
modifications, a very complex scenario can be envisioned 
that still requires a great deal of research to disentangle.
In summary, these results indicated that NUMB 
and NUMBL could differentially modulate different 
signaling pathways in a very different fashion, indicating 
that, despite the previously observed exclusivity, the 
full redundancy does not exist between these two 
genes. Only in the Notch pathway, equal regulation is 
maintained. However, the similar phenotypic effect 
is observed under the downregulation of each protein 
independently, suggesting that Notch pathway regulation 




To determine the correlation between NUMB and 
NUMBL genes in acute amyloid leukemia (AML), acute 
lymphoblastic leukemia (ALL), chronic lymphocytic 
leukemia (CLL), ovarian, colon/rectal, lung, renal, breast, 
neuroblastoma and esophagus tumors, a total of 95 different 
databases and 19 normal datasets were analyzed using R2 
software (Genomics Analysis and Visualization Platform, 
http://r2.amc.nl). All datasets are freely available at the R2 
webpage. To perform these correlations, the 209073_s_at 
probe was used for NUMB and the 242195_x_at for 
NUMBL. In addition, for NUMB vs. NUMBL heat maps, 
we used TCGA datasets for Colon Adenocarcinoma and 
Kidney Renal Clear Cell Carcinomas, Bild dataset for 
tumor lung (GSE3141), and the EXPO dataset for breast 
and endometrium tumors (GSE2109).
To analyze the methylation state of NUMB 
and NUMBL in human samples, we used the TCGA 
Wanderer resource (http://maplab.imppc.org/wanderer/) 
[42], using the datasets for Breast Invasive Carcinoma, 
Colon Adenocarcinoma, Rectum Adenocarcinoma, Lung 
Adenocarcinoma, Lung Squamous Cell Carcinoma and 
Cervical squamous cell carcinoma and endocervical 
adenocarcinoma. Only CG probes with beta value higher 
than 0.1 were considered for the analysis.
To identify genes correlated with NUMB and 
NUMBL, a total of 28 databases of different tumors 
(breast, lung, colon and cervix; Supplementary Table 1) 
were analyzed using R2 software. All datasets are freely 
available at the R2 webpage. We looked for correlations 
using probles 209073_s_at (NUMB) or 242195_x_at 
(NUMBL) for all Affymetrix datasets. For the Budinska 
dataset, we used the ADXCRIH.2944.C1_at probe for 
NUMB and the ADXCRAG_AF015041_at probe for 
NUMBL, while for the TCGA datasets, we used the 
NUMB_8650 probe for NUMB and the NUMBL_9253 
probe for NUMBL. In all cases, we established a p-value 
lower than 0.05 to identify significant differences. 
From the list of correlated genes, we separated 
genes that were positively correlated to NUMB or 
NUMBL from genes that were negatively correlated to 
NUMB or NUMBL, generating two gene lists for each 
database and gene. Next, we searched for genes that were 
Figure 8: NUMB and NUMBL affect Notch, WNT and Hedgehog pathways differentially.
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highly represented among the different datasets. Thus, we 
established a cutoff for each gene of appearing at least in 
two different databases in cervical cancer, three different 
databases in lung cancer, four different databases in 
breast cancer and six different databases in colon cancer. 
We thereby generated four groups of genes that were 
commonly negatively or positively correlated to NUMB or 
NUMBL. To generate a Venn diagram to identify common 
genes that were correlated to NUMB or NUMBL for all 
tumors, we used the tool Venny [75].
To identify the pathways or Gene Ontology (GO) 
terms linked to genes that were positively or negatively 
correlated to NUMB or NUMBL, we used enrichment 
analysis from the Gene Ontology consortium webpage 
(http://geneontology.org/page/go-enrichment-analysis). 
In addition, we used Reactome (https://reactome.org/) to 
find altered pathways correlated to NUMB or NUMBL. 
In both cases, we only take into account genes with a 
p-value lower than 0.05. For Reactome pathways, in 
addition, we only considered pathways with a FDR lower 
than 0.05.
To detect correlations between NUMBL and genes 
related to the Notch, WNT or Hedgehog pathways, we 
used the same previously considered 28 databases of 
different tumors (breast, lung and colon; Supplementary 
Table 1), fixing a p-value lower than 0.05 to identify 
statistically significant correlations. 
Cell lines and cellular assays
T47D and HeLa cells were obtained from the 
European Collection of Authenticated Cell Cultures 
(ECACC) commercial repository at the beginning of 
this study. No further authentication was performed for 
these cell lines. Cells were maintained in DMEM (Sigma) 
supplemented with 10% FBS (Life Technologies), penicillin, 
streptomycin, and fungizone. To downregulate NUMB and 
NUMBL expression, we used shRNA plasmids from Origene 
(TR311064, TR311063, Rockville, MD) as previously 
described [17, 48]. All transfected cells were selected with 
1 μg mL–1 of puromycin.
Protein isolation and western blot analysis
Protein extracts for Western blot analysis were 
obtained as described previously [17]. For Western blot 
detection, we used NUMB (ab4147, Abcam, 1 μg/mL) and 
NUMBL (ab37500, Abcam, 1 μg/mL) antibodies. α-Tubulin 
(T9026, Sigma) was used as a control. Horseradish 
peroxidase-labeled rabbit anti-mouse (ab97046, Abcam, 
diluted 1:5,000) and goat anti-rabbit (ab97051, Abcam, 
diluted 1:5,000) secondary antibodies were used.
Analysis of gene transcription
Total RNA was purified as described previously [17]. 
To detect changes in gene expression, we used the following 
probes, all from Life Technologies: NUMB (Hs01105433_
m1), NUMBL (Hs00191080_m1), HES1 (Hs00172878_
m1), HES5 (Hs01387463_g1), KLF7 (Hs00748636_s1), 
NFKB1 (Hs00765730_m1), ERBB2 (Hs01001580_m1), 
TEAD1 (Hs00173359_m1), TCF4 (Hs00162613_m1), EN1 
(Hs00154977_m1), BTRC (Hs00182707_m1), SOX9 
(Hs01001343_g1), PTCH1 (Hs00181117_m1), GLI1 
(Hs01110766_m1), GLI2 (Hs01119974_m1), CDH1 
(Hs01023895_m1), SOX2 (Hs01053049_s1), BMI1 
(Hs00995536_m1), NANOG (Hs04260366_g1) and 
GAPDH (Hs03929097_g1). Quantitative PCR was 
performed as described previously [17]. 
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